MetLife Inc 5.625% Series E Preferred Stock
MET.PRE
2 hedge funds and large institutions have $6.94M invested in MetLife Inc 5.625% Series E Preferred Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
9% more capital invested
Capital invested by funds: $6.38M → $6.94M (+$558K)
0% more ownership
Funds ownership: 0.86% → 0.86% (+0%)
50% less funds holding
Funds holding: 4 → 2 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CGH
Crossmark Global Holdings
Houston,
Texas
|
+$90.3K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$11.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RFA
Register Financial Advisors
Atlanta,
Georgia
|
-$69.1K |
MET.PRE Hedge Fund Activity: Q1 2023 in Review
2 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) for Q1 2023, worth a combined $6.94M — up 8.7% from $6.38M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MET.PRE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Crossmark Global Holdings, adding an estimated $90.3K. The largest seller was Register Financial Advisors, exiting entirely with an estimated $69.1K sold.
- 2 institutional investors held MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) as of Q1 2023, down from 4 in Q4 2022.
- Funds reported $6.94M of MetLife Inc 5.625% Series E Preferred Stock stock for Q1 2023, up 8.7% quarter-over-quarter.
- 0 funds opened new MetLife Inc 5.625% Series E Preferred Stock positions in Q1 2023 and 1 closed out, a net change of -1 holder.
- The largest MetLife Inc 5.625% Series E Preferred Stock buyer in Q1 2023 was Crossmark Global Holdings, an estimated $90.3K added.
- The largest MetLife Inc 5.625% Series E Preferred Stock seller in Q1 2023 was Register Financial Advisors, an estimated $69.1K sold.
Based on aggregated 13F filings for Q1 2023.